Table 2.
Survival and SAIDS-Defining Pathology
| Animal ID | Depo-Provera®administration | SAIDS defining pathology | Survival after SIV infection (weeks) | Viral load (RNA copies/ml) | Terminal CD4 count (/μl) | SAIDS |
|---|---|---|---|---|---|---|
| Group 1 | ||||||
| 3771 | Yes | None | 70 | 133,013 | 247 | No |
| 3772 | Yes | Adenovirus enteritis; giant cell lymphadenitis | 68 | 174,636 | 207 | Yes |
| 3777 | Yes | None | 71 | 121,067 | 310 | No |
| 3779 | Yes | SIV encephalitis and myelitis; SIV giant cell pneumonia and lymphadenitis; adenovirus enteritis | 43 | 1,068,658 | 171 | Yes |
| 3784 | Yes | None | 72 | 640,690 | 214 | No |
| 3786 | Yes | SIV encephalitis and meningitis; SIV giant cell pneumonia | 69 | 151,276 | 284 | Yes |
| 3788 | Yes | None | 71 | 99,546 | 184 | No |
| 3790 | Yes | SIV arteriopathy; SIV encephalitis | 70 | 2,847,848 | 230 | Yes |
| 3794 | Yes | Enterocytozoon bieneusi cholecystitis | 72 | 1,142,649 | 177 | Yes |
| 3819 | Yes | None | 73 | 537,041 | 584 | No |
| Group 2 | ||||||
| 3774 | No | None | 68 | 170,119 | 482 | No |
| 3776 | No | None | 71 | 34,572 | 548 | No |
| 3781 | No | Adenovirus enteritis; lymphoproliferative disorder | 51 | 1,154,261 | 316 | Yes |
| 3782 | No | None | 72 | 24,018 | 228 | No |
| 3798 | No | Adenovirus enteritis | 69 | 539,519 | 423 | Yes |
| 3809 | No | E. bieneusi cholecystitis and cholangiohepatitis | 70 | 829,080 | 103 | Yes |
| 3812 | No | None | 68 | 37,557 | 296 | No |
| 3818 | No | None | 73 | 1,515,619 | 78 | No |
| 3821 | No | SIV encephalitis; adenovirus enteritis | 51 | 116,176 | 199 | Yes |
| 3826 | No | Pneumocystis carinii pneumonia; E. bieneusi cholecystitis | 69 | 1,352,781 | 168 | Yes |